Author Archives: Scalper1

ServiceNow Earnings May Be Indicator For Sector

Shareholders of ServiceNow (NOW) are awaiting Wednesday’s Q3 earnings to see whether the business-software maker can live up to expectations and more than double its EPS, and if so, whether that indicates a solid quarter for business-software firms overall. ServiceNow is expected to report EPS ex items of 8 cents, up from 3 cents in Q3 2014, according to analysts polled by Thomson Reuters. Revenue is forecast to rise 43% to $256.2 million. The

Valeant Unveils Strategy For New Era Of Drug Pricing

Drug giant Valeant Pharmaceuticals beat Q3 estimates and raised its guidance Monday, but the stock fell 7.7% as the CEO admitted that recent controversy over its high drug prices is leading to new strategies, including a possible sale of Valeant’s neurology business. On a conference call to discuss Q3 earnings Monday morning, Valeant (VRX) CEO J. Michael Pearson said the company will be adjusting its strategy in light of recent